Beta-carotene (BC) was found to enhance lung cancer risk in smokers. This adverse effect was unexpected because BC was thought to act as an anti-oxidant against cigarette smoke-derived radicals. These radicals can directly or indirectly damage DNA, leading to the formation of pro-mutagenic DNA lesions such as 8-oxo-7,8-dihydro-2#-deoxyguanosine (8-oxo-dG) and 3-(2-deoxy-b-D-erythropentafuranosyl)pyrimido[1,2-a]purin-10(3H)-one deoxyguanosine (M 1 dG). Later, it was suggested that high concentrations of BC could also result in pro-oxidant effects. Therefore, we investigated whether high but physiologically feasible concentrations of BC were able to alter (i) the formation of radicals in vitro assessed by electron spin resonance spectroscopy, (ii) the levels of 8-oxo-dG and M 1 dG in vitro in lung epithelial cells after incubation with hydrogen peroxide (H 2 O 2 ) and the smoke-derived carcinogen benzo[a]pyrene (B[a]P) and (iii) the levels of 8-oxo-dG and M 1 dG in vivo in ferrets' lung after chronic exposure to B[a]P. BC increased in vitro hydroxyl radical formation in the Fenton reaction but inhibited the formation of carbon-centered radicals. Similarly, BC was able to enhance 8-oxo-dG in vitro in lung epithelial cells. On the other hand, BC significantly inhibited M 1 dG formation in lung epithelial cells, especially after induction of M 1 dG by H 2 O 2 or B[a]P. Finally, BC supplementation of ferrets also resulted in a significant decrease in M 1 dG, but in contrast to the in vitro experiments, no effect was observed on 8-oxo-dG levels, probably because of increased base excision repair capacities as assessed by a modified comet assay. These data indicate that the fate of BC being a pro-or anti-oxidant strongly depends on the type of radical involved.
Introduction
The consumption of high concentrations of beta-carotene (BC), predominantly present in fruits and vegetables, is associated with a lower incidence of cardiovascular diseases and several types of cancers (1) .
This was attributed to the anti-oxidant properties of BC (2) . However, two human intervention trials unexpectedly demonstrated that BC supplementation alone, Alpha-Tocopherol, Beta-carotene Cancer prevention study (ATBC), or in combination with vitamin A, Carotene and Retinol Efficacy Trial (CARET), had adverse effects including an increased lung cancer risk in smokers, suggesting that a high BC intake can enhance smoke-induced carcinogenesis (3, 4) . The mechanism behind this increased lung cancer risk upon BC supplementation is still not elucidated, but an interaction of BC with cigarette smokeinduced processes or constituents is likely, because no detrimental effects of BC were observed in non-smokers (5) .
Cigarette smoke contains many genotoxic compounds, including benzo[a]pyrene (B[a]P), one of the best studied chemical carcinogens (6) . Although the formation of B[a]P-related DNA adducts is an important contributor to the carcinogenicity of cigarette smoke (7) , other types of DNA lesions may also contribute to this mechanism. For instance, cigarette smoke contains many free radicals and oxidants (10 14 per puff), capable of damaging the DNA (8) . Further, inhalation of cigarette smoke results in an inflammatory response in the lung, and a role for chronic inflammation in lung carcinogenesis has been demonstrated by studies in which the use of anti-inflammatory drugs resulted in a reduction in the relative risk of lung cancer in smokers (9, 10) . During inflammation, large amounts of reactive oxygen species (ROS) are produced that can directly interact with DNA to form pro-mutagenic DNA lesions, with the most studied lesion being 8-oxo-7,8-dihydro-2#-deoxyguanosine (8-oxo-dG) (11) . ROS can also indirectly damage DNA by reacting with lipids first, causing lipid peroxidation (LPO), and a subsequent binding of these LPO products to the DNA. An important LPO product is malondialdehyde (MDA), able to form the pro-mutagenic MDA-derived DNA adduct 3-(2-deoxy-b-D-erythro-pentafuranosyl)pyrimido[1,2-a]purin-10(3H)-one deoxyguanosine (M 1 dG) (12) . DNA adducts can result in mutations and are considered to be an important first step in carcinogenesis. Anti-oxidants have the potential to neutralize both ROS and LPO, thereby decreasing the formation of genotoxic DNA lesions. BC is also regarded as an anti-oxidant, but an increasing number of studies show that BC can also act as a pro-oxidant [reviewed in ref. (13) ], able to enhance DNA lesion formation. Repair enzymes have the ability to restore these lesions; nucleotide excision repair enzymes specifically recognize bulky DNA adducts such as M 1 dG, whereas base excision repair (BER) enzymes remove small lesions such as oxidized DNA bases like 8-oxo-dG. The modulation of DNA repair enzyme capacities can thus also result in altered levels of smoke-induced DNA lesions, ultimately leading to increased or decreased protection against DNA mutations (14, 15) .
The aim of this study was to assess the pro-and anti-oxidant properties of BC in vitro and in vivo to get more insight in the unexpected increase of lung cancer incidence in smokers who were supplemented with BC. We studied the modulating effect of BC supplementation on two major types of DNA lesions that are thought to be involved in smoke and oxidative stress-induced lung carcinogenesis: 8-oxo-dG and M 1 dG, in vitro and in vivo. Therefore, we exposed human lung epithelial cells to BC at a concentration of 5 lM, which was equal to the BC serum concentration in the ATBC and CARET study at the end of the interventions, in combination with the smokederived ROS generating B[a]P or hydrogen peroxide (H 2 O 2 ). To validate in vitro results, ferrets (Mustela putorius furo) were exposed to BC (based on the BC intake in the human intervention trials) in combination with or without B[a]P. Ferrets were used since they absorb and metabolize BC more comparable with humans than rodents and display increasing BC serum concentration with increasing BC intake, rather than increasing BC metabolite concentrations (16, 17) .
Materials and methods

BC stock solutions
The BC concentration (5 lM) that was used in the in vitro studies was based on serum concentrations observed in the CARET and ATBC study after 3 years of daily vitamin intake (18) . Stock solutions of all trans-BC (15 mM) (SigmaAldrich, Zwijndrecht, The Netherlands) with or without B[a]P (30 mM) and B[a]P alone (30 mM) (Sigma-Aldrich) were prepared in deperoxidized tetrahydrofuran (THF) and stored, including the THF control, in amber vials under argon at À80°C until use. THF was deperoxidized over an ALOX column (aluminium oxide-90 active basic, Merck, Darmstadt, Germany). Stock solutions were diluted 1:30 in heat-inactivated fetal calf serum (Gibco, Invitrogen, Breda, The Netherlands) to make BC better soluble in hydrophilic solutions. This solution was further diluted 1:100 in medium or water.
Pro-and anti-oxidant effects of BC assessed by electron spin resonance spectroscopy Iron sulphate (FeSO 4 ), H 2 O 2 and the spin traps: a-(4-pyridyl 1-oxide)-N-tertbutylnitrone (POBN) and 5,5-dimethyl-1-pyrolline N-oxide (DMPO) were purchased from Sigma-Aldrich. DMPO was dissolved in nitrogen-flushed water and purified by charcoal treatment. Concentrations of DMPO stocks were determined spectrophotometrically (e 5 7700/M/cm, 234 nm). Electron spin resonance (ESR) spectra were recorded at room temperature in glass capillaries (100 ll, Brand AG, Wertheim, Germany) in a Bruker EMX 1273 spectrometer equipped with an ER 4119HS high-sensitivity cavity and 12 kW power supply operating at X band frequencies. The modulation frequency of the spectrometer was 100 kHz. Instrumental conditions for the recorded spectra were as follows: magnetic field, 3490 G; scan range, 60 G; modulation amplitude, 1 G; receiver gain, 1 Â 10 5 ; microwave frequency, 9.85 GHz; power, 50 mW; time constant, 40.96 ms; scan time, 20.97 s; number of scans, 10 when using the spin-trap DMPO and 20 when using the spin-trap POBN. Surface area and hyperfine coupling constants of the peaks were calculated using the WIN-EPR spectrum manipulation program (Bruker, Billerica, MA). To assess the formation of hydroxyl radicals (ÁOH) or carbon-centered radicals (ÁC), FeSO 4 (20 lM) was mixed with the spin-trap DMPO (100 mM) or POBN (100 mM), respectively, and solvent (control) with or without BC (5 lM). H 2 O 2 (100 lM) was added to start the reaction. Exactly 2 min after the addition of H 2 O 2 , the spectrum was recorded and every condition was tested in triplicate.
DNA damage in lung epithelial cells Pro-and anti-oxidant effects of BC on H 2 O 2 -or B[a]P-induced genotoxicity in A549 and BEAS-2B lung epithelial cells were studied. For this, the human epithelial lung carcinoma cell line A549 was cultured in Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal calf serum (Life Technologies, Invitrogen, Breda, The Netherlands), 1% penicillin and 1% streptomycin (Sigma-Aldrich) and the human SV40 transformed lung cell line BEAS-2B was cultured in RPMI 1640 containing L-glutamine (Sigma) and supplemented with 5% fetal calf serum, 1% penicillin, 1% streptomycin, 1Â non-essential amino acids and 10 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid (Gibco). Both cell lines were cultured at 37°C in a 5% CO 2 atmosphere. Cells were cultured in T75 flasks and 48 h prior to H 2 O 2 or B[a]P exposure, medium supplemented with or without 5 lM BC was refreshed daily to ensure the presence of intact BC in the cells (19) . After 48 h, 80% confluent cells were exposed to fresh medium with or without B[a]P (10 lM) or H 2 O 2 (100 lM) in combination with or without BC (5 lM). Experiments were performed in quadruplet and 1 h after H 2 O 2 exposure and 16 h after B[a]P exposure cells were harvested. From the cells, DNA was isolated and assayed for 8-oxo-dG and M 1 dG (see below).
Ferret housing, treatment and lung collection
The calculation of the ferret equivalent of BC doses as used in the human ATBC and CARET intervention trials ($30 mg/day in a 70 kg person) was based on previous reports (17, 20) and was based on total absorption of intact BC. Ferrets were housed and treated as described by Fuster et al. (21) . Briefly, female 7-week-old ferrets (Exopet AB, Glommen, Sweden) were fed ad libitum (Friskies). After 1 week of adaptation, ferrets were randomly assigned in five groups of six animals receiving the following diets: control formulation (Co); 0.8 mg BC/kg/day (BC 0.8) which is equivalent to $10 mg BC/day in a 70 kg person; 3.2 mg BC/kg/day (BC 3.2) which is equivalent to $40 mg BC/ day; control formulation in combination with exposure to 8 mg B[a]P/kg three times a week for 10 weeks by oral gavage (B[a]P) and 0.8 mg BC/kg/day in combination with exposure to 8 mg B[a]P/kg three times a week for 10 weeks by oral gavage (BC-B[a]P). BC was provided every morning for 6 months as a water-soluble formulation by DSM Nutritional Products Ltd (Basel, Switzerland), which contained crystalline BC, DL-alpha-tocopherol, ascorbyl palmitate, corn oil, fish gelatine, sucrose and corn starch. B[a]P treatment started 1 week after beginning the treatment with BC. Formulations with or without BC were dissolved in 200 ll water and given to the animals. After the 6 months treatment, ferrets were anesthetized using 10 mg/kg ketamine hydrochloride (Imalgène 1000, Merial Laboratorios SA, Lyon, France) and 80 lg/kg medetomidine (Domtor, Orion Pharma, Espoo, Finland). Arterial blood was collected. Animals were killed by exsanguinations; lung tissue was collected, snap frozen in liquid nitrogen and stored at À80°C until analysis.
DNA isolation for M 1 dG and 8-oxo-dG measurement Lung was cut into small pieces in a solution containing 100 mM NaCl, 20 mM ethylenediaminetetraacetic acid, 50 mM Tris-HCl, 25 mM 2,2,6,6-tetramethylpiperidine-1-oxyl and 0.5% sodium dodecyl sulfate. RNase A (0.1 mg/ml) and RNase T1 (1000 U/ml) were added and samples were incubated at 37°C for 1 h. Thereafter, proteinase K was added (1 mg/ml) and incubation was continued overnight at 37°C. The aqueous phase was successively extracted with equal volumes of phenol:chloroform:isoamyl alcohol (25:24:1) containing 8-hydroxyquinoline and chloroform:isoamyl alcohol (24:1). The DNA was then precipitated using 2 vols of ice-cold ethanol after addition of 1/30 vols sodium acetate (3 M) and washed with 70% ethanol. DNA was dried under nitrogen and dissolved in 2 mM Tris (pH 7.4) at a concentration of 0.5 mg/ml. 2,2,6,6-Tetramethylpiperidine-1-oxyl and 8-hydroxyquinoline were added to prevent artificial formation of 8-oxo-dG. All DNA samples had an A260/A280 . 1.8 and an A230/A260 $0.45, indicating the purity of the DNA.
Preparation of the reference M 1 dG standards Reference adduct standards were used for the optimization of the 32 P-DNA post-labeling procedure. We prepared the reference adduct standards by treating calf thymus (CT) DNA with 10 mM MDA according to published condition (22) , yielding M 1 dG (22) (23) (24) . MDA-treated CT-DNA was then diluted with untreated CT-DNA to obtain decreasing levels of the reference adduct standard to generate a calibration curve (R 2 5 0.99). (25) with minor modifications. M 1 dG standards were prepared according to published conditions (22) in which CT-DNA (1 mg/ml) was incubated in vitro with 10 mM MDA. DNA was digested by micrococcal nuclease and spleen phosphodiesterase (26) . Hydrolyzed samples were subsequently treated with 2.5 lg of nuclease P1 for 30 min at 37°C. The nuclease P1-resistant nucleotides were incubated with 15-25 lCi of [c-32 P]-ATP (3000 Ci/mmol) and T4-polynucleotide (0.75 U/ll) to generate 32 P-labeled M 1 dG, which were subsequently separated by thin layer chromatography (25) . 32 P-labeled products were applied to the origin of chromatograms and developed with 0.35 MgCl 2 up to 2.0 cm filter paper wick. Plates were developed in the opposite direction with 2.1 M lithium formate, 3.75 M urea, pH 3.75, and then run at the right angle to the previous development with 0.24 M sodium phosphate, 2.4 M urea, pH 6.4.
Detection and quantification of M 1 dG and total nucleotides was obtained by storage phosphor imaging technique employing intensifying screens from Molecular Dynamics (Sunnyvale, CA) for 0.20-48 h. The screens were scanned using a Typhoon 9210 (Amersham, Buckinghamshire, UK). Software used to process the data was ImageQuant (Molecular Dynamics). After background subtraction, the levels of M 1 dG were expressed as relative adduct labeling 5 screen pixel in adducted nucleotides/screen pixel in total nucleotides. To calculate the levels of total nucleotides, aliquots of hydrolyzed DNA were appropriately diluted and reacted in the same mixtures used for M 1 dG labeling. The obtained 32 P-labeled total nucleotides were separated on Merck polyethyleneimine-cellulose thin layer chromatography plates using 280 mM (NH 4 ) 2 SO 4 and 50 mM NaH 2 PO 4 . The values measured for M 1 dG were corrected across experiments based on the recovery of standard M 1 dG after the 32 P-DNA post-labeling assay.
High-performance liquid chromatography/electrochemical detection analysis of 8-oxo-dG Oxidative damage in DNA was evaluated as described previously (27) and was expressed as the ratio of 8-oxo-dG to deoxyguanosine. In short, DNA was digested into deoxyribonucleosides by treatment with nuclease P1 (0.02 U/ll) and alkaline phosphatase (0.014 U/ll). The digest was then injected into a Gynkotek 480 isocratic pump (Gynkotek, Bremen, Germany) coupled with a Midas injector (Spark Holland, Hendrik Ido Ambacht, The Netherlands) and connected to a Supelcosil TM LC-18S column (250 Â 4.6 mm) (Supelco Park, Bellefonte, PA) and an electrochemical detector (Antec, Leiden, The Netherlands). The mobile phase consisted of 10% aqueous methanol containing 94 mM KH 2 PO 4 , 13 mM K 2 HPO 4 , 26 mM NaCl and 0.5 mM ethylenediaminetetraacetic acid. Elution was performed at a flow rate of 1.0 ml/min with a lower detection limit of 40 fmol absolute for 8-oxo-dG or 1.5 residues/10 6 2#-deoxyguanosine. Deoxyguanosine was simultaneously monitored at 260 nm.
BC affects oxidative stress-related DNA damage in lung epithelial cells and in ferret lung BER assay BER capacity was measured as described previously (28) , with some minor modifications. Pairs of gels containing $5 Â 10 4 A549 substrate cells [exposed to 1 mM Ro 19-8022 (Roche, Basel, Switzerland) and irradiated 5 min, 33 cm from a 500 W halogen lamp] in 100 ll of 1% low-melting point agarose (Invitrogen Life Technologies) were placed on glass microscope slides pre-coated with 1.5% normal melting point agarose. The gels were covered with glass cover slips and allowed to solidify for 30 min at 4°C, after which they were lysed overnight in 2.5 M NaCl, 0.1 M ethylenediaminetetraacetic acid, 10 mM Tris, 1% Triton X-100 and 10% dimethyl sulfoxide, pH 10, at 4°C. Slides were washed 3 Â 5 min with reaction buffer. Forty-five microliters of lung protein extract (1 mg/ml) was added to each gel, covered with a cover slip and incubated for 10 min at 37°C. As a negative control, reaction buffer alone was used and as a positive control 2.5 lg/ml formamidopyrimidine DNA glycosylase (kindly provided by Bernd Epe, University of Mainz, Mainz, Germany). After incubation, slides were immediately processed according to the conventional comet assay (29) 
Results
BC affects ÁOH and ÁC formation in vitro
The DMPO-trapped ÁOH (DMPO/ÁOH) signal was predominant [coupling constants: a(N) 5 14.86 G, a(b-H) 5 14.71 G] (Figure 1a ) in an acellular Fe 2þ /H 2 O 2 system but also included other small DMPOtrapped radical signals including possible ÁC (DMPO/ÁC) peaks, most probably derived from THF. BC (5 lM) increased the DMPO/ÁOH signal by 43%, as was published before (29) , whereas the DMPO/ÁC peaks completely disappeared (Figure 1a and b) . Therefore, the inhibition of ÁC by BC was further studied by ESR spectroscopy combined with the spin-trap POBN, which is more specific for ÁC M 1 dG was quantified using 32 P-DNA post-labeling by measuring the intensity of the specific M 1 dG spots (Figure 4) . In contrast to the effect of BC supplementation on 8-oxo-dG formation, BC supplementation significantly reduced M 1 dG and BC had the tendency to reduce H 2 O 2 (P 5 0.06) and reduced B[a]P (P , 0.001)-induced M 1 dG levels in lung epithelial cells ( Figure 5 ).
BC supplementation modulates B[a]P-induced genotoxicity in ferrets
BC supplementation resulted in increased BC plasma concentrations compared with ferrets that were not supplemented with BC, as was published previously (21) . BC supplementation did not lead to altered levels of 8-oxo-dG in ferret lung DNA compared with the controls (Figure 6a ), whereas B[a]P exposure, in contrast to the in vitro experiments, reduced 8-oxo-dG in ferret lung DNA (P , 0.01). Moreover, BC-supplemented ferrets had significantly reduced M 1 dG levels (P , 0.05) compared with non-supplemented ferrets (Figure 6b ). There was no effect of B[a]P exposure on M 1 dG levels in vivo in ferrets.
Two contradictions were observed between in vitro and in vivo experiments. First, in vivo BC supplementation did not increase 8-oxo-dG levels as was observed in vitro. Second, B[a]P exposure increased 8-oxo-dG levels in vitro in lung epithelial cells but significantly decreased 8-oxo-dG levels in vivo. Both contradictions might be explained by repair of oxidative DNA damage by BER, and therefore, effects of BC and B[a]P exposures on BER capacities in ferret's lung were further investigated by a modified comet assay. BC exposure led to an increased BER capacity, but this did not reach statistical significance (P 5 0.08). On the other hand, B[a]P exposure significantly increased BER capacity in ferret lung (P , 0.001) as can be seen in (Figure 6c) . 
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Discussion
We investigated the in vitro and in vivo anti-and pro-oxidant properties of BC in relation to DNA-damaging effects in lung epithelial cells in vitro and in vivo in lung tissue of ferrets. Although we found no anti-oxidant properties of BC against ROS, BC did have strong anti-oxidant properties toward ÁC. These ÁC are important intermediates in LPO, which in turn are capable of inducing DNA damage (12) . Indeed, we observed lower levels of the LPO-derived M 1 dG adducts in vitro as well as in vivo after BC supplementation. On the other hand, BC acted as a pro-oxidant with regard to ÁOH formation in the Fenton reaction and consequently BC supplementation in vitro to lung epithelial cells increased oxidation of DNA, measured as the promutagenic lesion 8-oxo-dG. In vivo in ferret lung, however, BC supplementation did not increase 8-oxo-dG levels, probably because of improved BER capacities to counteract the formation of 8-oxo-dG. We show in this study that a high but physiologically relevant BC concentration can exert a dual role; being an effective anti-oxidant on one hand for ÁC and on the other hand being a pro-oxidant in the irondependent Fenton reaction that generates ÁOH. Although both proand anti-oxidant properties of BC are also suggested in other studies (32, 33) , this study designates the fate of BC being a pro-oxidant or anti-oxidant to be dependent on the type of radical. Indeed, previous studies focusing on LPO products mainly designate BC as being an anti-oxidant. For example, Shih et al. (34) found that BC was able to decrease cholesterol-induced LPO in liver and plasma of rats. Although LPO products can be considered to be important markers in carcinogenesis, no study thus far focused on the influence of BC on LPO-induced DNA adducts. We show in this study that BC can reduce LPO-induced genotoxicity in vitro and in vivo. In contrast, most studies that appoint BC as a pro-oxidant are performed under conditions where oxygen seems to be an important mediator. For example, Alija et al. (35) demonstrated that BC enhanced genotoxicity of oxidative stress after re-oxygenation of hypoxic rat hepatocytes. In another study, BC was not able to scavenge ROS generated by a xanthine/ xanthine oxidase system. However, physiologically irrelevant concentrations of BC were used in that study (36) . Moreover, we showed previously that BC metabolites were able to increase oxidative DNA damage during a co-culture experiment with activated neutrophils and A549 lung epithelial cells (29) . In this study, we observed a prooxidant effect of BC in our acellular ESR experiments when ÁOH were involved and in vitro on 8-oxo-dG levels. This pro-oxidant effect in vitro was independent of additional exposure to H 2 O 2 or B[a]P, which indicates that BC was able to increase endogenously generated ROS. Important ROS-producing organelles are mitochondria, and previously Siems et al. (37, 38) found that BC cleavage products were able to impair mitochondrial functioning, which possibly leads to an BC affects oxidative stress-related DNA damage in lung epithelial cells and in ferret lung increased formation of 8-oxo-dG and might explain our in vitro results with epithelial cells.
We were interested in the effects of BC on ÁC radical formation and ultimately on the level of MDA-derived DNA adducts (M 1 dG). MDA is a natural product of LPO and several studies show significant correlations between M 1 dG formation and LPO products (39) . For example, high levels of x-6 polyunsaturated fatty acids in the diet have been associated with increased levels of M 1 dG (40, 41) . Furthermore, levels of M 1 dG significantly correlate with etheno-DNA adducts, which are induced by LPO by-products such as acrolein, croton aldehyde and trans-4-hydroxy-2-nonenal (41). Besides these studies that imply an important role for LPO in M 1 dG formation, Dedon et al. proposed a mechanism in which M 1 dG can also be formed directly upon H 2 O 2 exposure to isolated DNA through the formation of base propenal (42, 43) . Although this direct route might also be important in the formation of M 1 dG, these results are mainly based on experiments using naked DNA. Jeong et al. (44) found that fatty acids decrease the direct formation of M 1 dG and the amount of M 1 dG formed is dependent on the saturation of the fatty acids, indicating that the ability of fatty acids to form LPO is still important in the formation of M 1 dG. The presence of fatty acids is physiologically more relevant than a system without fatty acids. Although there might be some debate on the exact mechanism of M 1 dG formation, LPO is, at least in part, involved in the formation of M 1 dG and ÁC radicals are also important intermediates in the direct M 1 dG formation. We showed that BC was able to scavenge ÁC radicals and not ÁOH or O ÀÁ 2 [as shown previously (29)] radicals. Therefore, these results are in line with the hypothesis that BC is able to scavenge ÁC radicals and thereby is able to decrease M 1 dG.
When investigating effects of BC in humans, it is important to use in vitro and in vivo models that represent physiological conditions as much as possible. In humans, around 30-40% of all ingested BC is absorbed intact. Therefore, an increase in BC intake has been shown to result in increased plasma BC levels. A total of 60-70% of the ingested BC is converted into retinal, which subsequently can be further metabolized into retinol and retinol derivatives (45) . To investigate effects of BC, the in vitro and in vivo model systems should both have the property to take up intact BC and to metabolize BC comparable with the human situation. Several human colon and lung cell lines were previously tested, including BEAS-2B, on the intracellular levels of BC and BC metabolites after exposure to 1 lM BC for 2 h up to 3 weeks. All cell lines were able to accumulate intact BC (19) . We exposed cells for 59 or 64 h, which was an exposure time required for a stable BC concentration in cell culture experiments. Moreover, all cell lines previously tested, including BEAS-2B, were able to metabolize BC. However, the type and exact concentration of BC metabolites in the cells differed between cell lines. Moreover, various cell lines are expected to express anti-oxidant enzymes differently. To circumvent a strong bias due to cell line used, we used both BEAS-2B and A549 lung epithelial cells and we used an animal model to further validate our results. The often used laboratory animal models, which are mainly rodents, have the disadvantage that BC is entirely cleaved and BC research is therefore virtually impossible (17) . Ferrets are known to possess a BC metabolism more comparable with humans, with an increase in both BC and BC metabolites upon an increased BC intake (17) . We have taken BC metabolism as well as BC concentration into account in our experiments aiming to be as close as possible to known human physiological conditions. We used ESR, in vitro as well as in vivo models, to assess the effect of BC on oxidative DNA damage. Whether there was a significant effect of BC on 8-oxo-dG formation was mainly dependent on the experimental models that were used. We showed with these methods that BC was able to decrease ÁC in the ESR and M 1 dG formation in vitro as well as in vivo. Although these results demonstrate similar effects, there were some differences regarding the extent of the effects. There are some potentially confounding factors when performing in vitro experiments with BC, which have been discussed and reviewed previously (46) . For example, BC is highly lipophillic and THF was used to dissolve BC into the medium and medium sometimes contains relatively high concentrations of certain vitamins. These differences in vitamin concentrations and the use of a solvent might be an additional factor, which can cause differences in the induction of 8-oxo-dG and the extend of the effect on M 1 dG. Moreover, it should be noted that the BC used in our in vivo experiment was a water-soluble formulation, containing DL-alpha-tocopherol and ascorbyl palmitate as stabilizers, while this was not the case in the in vitro experiments. The BC formulation might thus have influenced our end points in vivo. Effects of BC supplementation may be more pronounced, when supplemented without alpha-tocopherol. Palozza et al. (47) demonstrated previously that increased formation of peroxidation products in lung microsomal membranes by BC upon an increase in pO 2 was partly reduced by alpha-tocopherol. Moreover, two different studies exposed ferrets to low and high BC concentrations but used different formulations of BC; Liu et al. (20) used a formulation of BC in corn oil, whereas Fuster et al. (21) used the same formulation as in this experiment containing DL-alpha-tocopherol and ascorbyl palmitate as stabilizers. Relative expression of the same cell cycle and proliferation enzymes varied between both studies and were more pronounced in the study using corn oil. A possible explanation for this effect is that radical cycling between alpha-tocopherol, ascorbyl palmitate and BC occurs and that therefore radical-induced effects are inhibited by a protective effect of alpha-tocopherol and ascorbyl palmitate as has been reviewed by Palozza (48) and Krinsky et al. (49) .
Although it is thought that B[a]P metabolism results in enhanced formation of ROS and 8-oxo-dG in vitro, B[a]P exposure resulted in decreased levels of 8-oxo-dG in ferret lung DNA, which was very persistent, since B[a]P exposure stopped 13 weeks before killing the animals. Decreased levels of 8-oxo-dG could possibly be explained by an induction of anti-oxidant or repair enzymes in vivo after B[a]P exposure. Briede et al. (50) already suggested a potential role for induced repair of 8-oxo-dG by B[a]P, since B[a]P exposure reduced 8-oxo-dG in rat lung, accompanied by an increase in urinary excretion of 8-oxo-dG/8-oxo-Gua. Here, we demonstrated that BER capacities were indeed improved upon B[a]P exposure. This finding might also indicate that toxins are able to trigger defense systems even long after the last dosage and that exposure to toxins might trigger endogenous protection systems. This is in accordance with a theory that mutagens do not necessarily act in a dose-response manner but that mutagens can induce the endogenous protection systems when occasionally consumed (51) .
Many studies indicating possible pro-oxidant activities of BC, including this study, are performed in vitro. Studies focusing on prooxidant effects of BC in vivo are largely lacking. Therefore, we investigated the effect of BC on the formation of 8-oxo-dG, an important genotoxic marker induced by oxidative stress in vivo in ferrets. There was no difference between steady-state levels of 8-oxo-dG in BC-supplemented groups compared with control groups, whereas BER capacity tended to be increased by BC supplementation. This suggests that a potential increase in oxidative stress was counterbalanced by an enhanced removal of lesions due to an increased BER capacity, restoring the steady state. Therefore, genotoxicity of BC might become important in conditions when simultaneously oxidative stress is induced and BER capacity is impaired. Smoking is such a situation where oxidative stress is increased and there are indications that repair is decreased (52, 53) .
In summary, we demonstrate that the fate of BC, being a prooxidant or an anti-oxidant, is dependent on the type of radicals involved. BC is an anti-oxidant regarding ÁC, able to significantly reduce M 1 dG levels in vitro as well as in vivo. On the other hand, BC has no ability to scavenge ÁOH and even results in an increased ROS production and subsequent formation of 8-oxo-dG in lung epithelial cells. 
